The aim of this study was to clarify the impact of various methodological q
uality factors on reported outcome of randomised clozapine trials. Trials c
omparing the atypical antipsychotic clozapine with other antipsychotic drug
s were identified in extensive electronic searches. Two independent reviewe
rs extracted data on methodology and primary outcomes, and assessed trial q
uality by use of three sets of criteria (Cochrane, Delphi, and Jadad). Ther
e was no association between trial quality, as measured by any of the crite
ria sets, and primary measures of outcome. Trials with the best score for r
andomisation and concealment according to the Delphi scale had a significan
tly lower relative risk for relapse in clozapine-treated groups, and studie
s with well reported random order generation according to Jadad criteria te
nded to have better odds ratios for clinical improvement on clozapine. Thes
e findings strengthen the evidence of true clozapine superiority in these a
spects, No other quality items correlated to the primary outcomes. Inadequa
te randomisation techniques may be a source of bias in clozapine studies, b
ut much more research is needed on the connections between trial quality an
d trial outcome.